Ligand ID: TF4


Drugbank ID:
DB08809
(Dichloroacetic Acid)



Indication:


Get human targets for TF4 in PDB (known and potential targets)

RESULTS FROM SUB-STRUCTURAL SIMILARITY SEARCHES MAPPED TO LIGAND 'TF4' AND SARS-COV-2 / COVID-19 STRUCTURES

1) User may click on the DrReposER ID (the first column) to get information on the binding sites and drug molecule.
2) Click View (the second last column) to view matched residues and superposition in the NGL viewer (upper right part).
3) User may also click on the Dock (the last column) to get script for molecular docking in UCSF Chimera throuh AutoDock Vina.


DrReposER ID / Desc. Hit
PDBID
Hit
Macromolecule
Res.
Matches
View Interface RMSD Seq.
Identity (%)
HETATM Dock
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2BU8_A_TF4A1379_1
(PYRUVATE
DEHYDROGENASE KINASE
ISOENZYME 2)
6m71 NSP12
NSP8
(SARS-CoV-2)
4 / 8
LEU A 271
ILE B 119
ILE B 106
ILE B 120
1.28A17.23
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2BU8_A_TF4A1379_1
(PYRUVATE
DEHYDROGENASE KINASE
ISOENZYME 2)
6m71 NSP8
(SARS-CoV-2)
4 / 8
LEU B 169
ILE B 156
ILE B 172
ILE B 132
1.57A18.89
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2BU8_A_TF4A1379_1
(PYRUVATE
DEHYDROGENASE KINASE
ISOENZYME 2)
6m71 NSP12
NSP8
(SARS-CoV-2)
4 / 8
LEU A 271
ILE B 107
ILE B 119
ILE B 120
1.35A17.23
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2BU8_A_TF4A1379_1
(PYRUVATE
DEHYDROGENASE KINASE
ISOENZYME 2)
6m71 NSP12
(SARS-CoV-2)
4 / 8
ILE A  86
HIS A  82
ILE A 223
ILE A 201
1.57A17.23
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2BU8_A_TF4A1379_1
(PYRUVATE
DEHYDROGENASE KINASE
ISOENZYME 2)
6vsb SPIKE GLYCOPROTEIN
(SARS-CoV-2)
4 / 8
TYR C 695
ILE C 666
ILE C 664
ILE C 312
1.00A14.91
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2Q8H_A_TF4A438_1
([PYRUVATE
DEHYDROGENASE
[LIPOAMIDE]] KINASE
ISOZYME 1)
6vww URIDYLATE-SPECIFIC
ENDORIBONUCLEASE
(SARS-CoV-2)
4 / 6
LEU B  76
TYR B 325
ILE B 144
ILE B  72
1.41A23.15
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2BU8_A_TF4A1379_1
(PYRUVATE
DEHYDROGENASE KINASE
ISOENZYME 2)
6vyb SPIKE GLYCOPROTEIN
(SARS-CoV-2)
4 / 8
TYR C 695
ILE C 666
ILE C 664
ILE C 312
1.09A15.00
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2BU8_A_TF4A1379_1
(PYRUVATE
DEHYDROGENASE KINASE
ISOENZYME 2)
6w4h SARS-COV-2 NSP16
(SARS-CoV-2)
4 / 8
LEU A6978
ILE A6955
ILE A6967
ILE A6925
1.27A21.52
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2BU8_A_TF4A1379_1
(PYRUVATE
DEHYDROGENASE KINASE
ISOENZYME 2)
6w4h SARS-COV-2 NSP16
(SARS-CoV-2)
4 / 8
LEU A6848
TYR A6845
ILE A6926
ILE A6967
1.14A21.52
None
SAM  A7102 ( 4.5A)
None
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2BU8_A_TF4A1379_1
(PYRUVATE
DEHYDROGENASE KINASE
ISOENZYME 2)
6w61 2'-O-METHYLTRANSFERA
SE
(SARS-CoV-2)
4 / 8
LEU A7078
ILE A7080
ILE A7069
ILE A7065
1.27A
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2BU8_A_TF4A1379_1
(PYRUVATE
DEHYDROGENASE KINASE
ISOENZYME 2)
6w61 2'-O-METHYLTRANSFERA
SE
(SARS-CoV-2)
4 / 8
LEU A6978
ILE A6967
ILE A6955
ILE A6925
1.51A
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2BU8_A_TF4A1379_1
(PYRUVATE
DEHYDROGENASE KINASE
ISOENZYME 2)
6w61 2'-O-METHYLTRANSFERA
SE
(SARS-CoV-2)
4 / 8
LEU A7078
ILE A7069
ILE A7080
ILE A7065
1.77A17.50
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2BU8_A_TF4A1379_1
(PYRUVATE
DEHYDROGENASE KINASE
ISOENZYME 2)
6w61 2'-O-METHYLTRANSFERA
SE
(SARS-CoV-2)
4 / 8
LEU A6848
TYR A6845
ILE A6926
ILE A6967
1.15A
None
SAM  A7104 (-4.6A)
None
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2BU8_A_TF4A1379_1
(PYRUVATE
DEHYDROGENASE KINASE
ISOENZYME 2)
6w61 2'-O-METHYLTRANSFERA
SE
(SARS-CoV-2)
4 / 8
LEU A7004
TYR A7026
HIS A7023
ILE A6969
1.76A17.50
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2BU8_A_TF4A1379_1
(PYRUVATE
DEHYDROGENASE KINASE
ISOENZYME 2)
6w61 2'-O-METHYLTRANSFERA
SE
(SARS-CoV-2)
4 / 8
LEU A6978
ILE A6955
ILE A6951
ILE A6925
1.39A
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2BU8_A_TF4A1379_1
(PYRUVATE
DEHYDROGENASE KINASE
ISOENZYME 2)
6w61 2'-O-METHYLTRANSFERA
SE
(SARS-CoV-2)
4 / 8
LEU A6978
ILE A6955
ILE A6967
ILE A6925
1.28A
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2BU8_A_TF4A1379_1
(PYRUVATE
DEHYDROGENASE KINASE
ISOENZYME 2)
6w61 2'-O-METHYLTRANSFERA
SE
(SARS-CoV-2)
4 / 8
ILE A6926
HIS A6867
ILE A6866
ILE A6925
1.57A
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2BU8_A_TF4A1379_1
(PYRUVATE
DEHYDROGENASE KINASE
ISOENZYME 2)
6w61 2'-O-METHYLTRANSFERA
SE
(SARS-CoV-2)
4 / 8
TYR A7009
ILE A6925
ILE A6955
ILE A6951
1.76A17.50
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2BU8_A_TF4A1379_1
(PYRUVATE
DEHYDROGENASE KINASE
ISOENZYME 2)
6w61 2'-O-METHYLTRANSFERA
SE
(SARS-CoV-2)
4 / 8
LEU A6852
ILE A6926
ILE A7005
ILE A6967
1.30A
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2BU8_A_TF4A1379_1
(PYRUVATE
DEHYDROGENASE KINASE
ISOENZYME 2)
6w61 2'-O-METHYLTRANSFERA
SE
(SARS-CoV-2)
4 / 8
LEU A7060
ILE A7080
ARG A7081
ILE A7079
1.69A
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2BU8_A_TF4A1379_1
(PYRUVATE
DEHYDROGENASE KINASE
ISOENZYME 2)
6w61 2'-O-METHYLTRANSFERA
SE
(SARS-CoV-2)
4 / 8
LEU A6848
ILE A6926
ILE A7005
ILE A6967
1.31A
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2BU8_A_TF4A1379_1
(PYRUVATE
DEHYDROGENASE KINASE
ISOENZYME 2)
6w75 NSP16
(SARS-CoV-2)
4 / 8
ILE A6926
HIS A6867
ILE A6866
ILE A6925
1.55A15.79
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2BU8_A_TF4A1379_1
(PYRUVATE
DEHYDROGENASE KINASE
ISOENZYME 2)
6w75 NSP16
(SARS-CoV-2)
4 / 8
LEU A7004
TYR A7026
HIS A7023
ILE A6969
1.73A15.79
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2BU8_A_TF4A1379_1
(PYRUVATE
DEHYDROGENASE KINASE
ISOENZYME 2)
6w75 NSP16
(SARS-CoV-2)
4 / 8
LEU A6978
ILE A6955
ILE A6951
ILE A6925
1.33A15.79
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2BU8_A_TF4A1379_1
(PYRUVATE
DEHYDROGENASE KINASE
ISOENZYME 2)
6w75 NSP16
(SARS-CoV-2)
4 / 8
LEU C7060
ILE C7080
ARG C7081
ILE C7079
1.68A15.79
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2BU8_A_TF4A1379_1
(PYRUVATE
DEHYDROGENASE KINASE
ISOENZYME 2)
6w75 NSP16
(SARS-CoV-2)
4 / 8
LEU A7078
ILE A7080
ILE A7069
ILE A7065
1.26A15.79
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2BU8_A_TF4A1379_1
(PYRUVATE
DEHYDROGENASE KINASE
ISOENZYME 2)
6w75 NSP16
(SARS-CoV-2)
4 / 8
LEU A6978
ILE A6955
ILE A6967
ILE A6925
1.26A15.79
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2BU8_A_TF4A1379_1
(PYRUVATE
DEHYDROGENASE KINASE
ISOENZYME 2)
6w75 NSP16
(SARS-CoV-2)
4 / 8
LEU A6848
TYR A6845
ILE A6926
ILE A6967
1.14A15.79
None
SAM  A7102 ( 4.5A)
None
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2BU8_A_TF4A1379_1
(PYRUVATE
DEHYDROGENASE KINASE
ISOENZYME 2)
6w75 NSP16
(SARS-CoV-2)
4 / 8
LEU C7078
ILE C7069
ILE C7080
ILE C7065
1.72A15.79
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2BU8_A_TF4A1379_1
(PYRUVATE
DEHYDROGENASE KINASE
ISOENZYME 2)
6w75 NSP16
(SARS-CoV-2)
4 / 8
LEU A7078
ILE A7069
ILE A7080
ILE A7065
1.72A15.79
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2BU8_A_TF4A1379_1
(PYRUVATE
DEHYDROGENASE KINASE
ISOENZYME 2)
6w75 NSP16
(SARS-CoV-2)
4 / 8
LEU C6978
ILE C6967
ILE C6955
ILE C6925
1.35A15.79
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2BU8_A_TF4A1379_1
(PYRUVATE
DEHYDROGENASE KINASE
ISOENZYME 2)
6w75 NSP16
(SARS-CoV-2)
4 / 8
LEU A7060
ILE A7080
ARG A7081
ILE A7079
1.64A15.79
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2BU8_A_TF4A1379_1
(PYRUVATE
DEHYDROGENASE KINASE
ISOENZYME 2)
6w75 NSP16
(SARS-CoV-2)
4 / 8
LEU C7078
ILE C7080
ILE C7069
ILE C7065
1.26A15.79
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2BU8_A_TF4A1379_1
(PYRUVATE
DEHYDROGENASE KINASE
ISOENZYME 2)
6w75 NSP16
(SARS-CoV-2)
4 / 8
LEU C6848
ILE C6926
ILE C7005
ILE C6967
1.30A15.79
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2BU8_A_TF4A1379_1
(PYRUVATE
DEHYDROGENASE KINASE
ISOENZYME 2)
6w75 NSP16
(SARS-CoV-2)
4 / 8
LEU C6978
ILE C6955
ILE C6951
ILE C6925
1.19A15.79
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2BU8_A_TF4A1379_1
(PYRUVATE
DEHYDROGENASE KINASE
ISOENZYME 2)
6w75 NSP16
(SARS-CoV-2)
4 / 8
LEU C7004
TYR C7026
HIS C7023
ILE C6969
1.75A15.79
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2BU8_A_TF4A1379_1
(PYRUVATE
DEHYDROGENASE KINASE
ISOENZYME 2)
6w75 NSP16
(SARS-CoV-2)
4 / 8
LEU C6978
ILE C6955
ILE C6967
ILE C6925
1.26A15.79
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2BU8_A_TF4A1379_1
(PYRUVATE
DEHYDROGENASE KINASE
ISOENZYME 2)
6w75 NSP16
(SARS-CoV-2)
4 / 8
LEU A7073
ILE A7080
ILE A7069
ILE A7065
1.75A15.79
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2BU8_A_TF4A1379_1
(PYRUVATE
DEHYDROGENASE KINASE
ISOENZYME 2)
6w75 NSP16
(SARS-CoV-2)
4 / 8
ILE C6926
HIS C6867
ILE C6866
ILE C6925
1.56A15.79
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2BU8_A_TF4A1379_1
(PYRUVATE
DEHYDROGENASE KINASE
ISOENZYME 2)
6w75 NSP16
(SARS-CoV-2)
4 / 8
LEU A6848
ILE A6926
ILE A7005
ILE A6967
1.30A15.79
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2BU8_A_TF4A1379_1
(PYRUVATE
DEHYDROGENASE KINASE
ISOENZYME 2)
6w75 NSP16
(SARS-CoV-2)
4 / 8
LEU A6852
ILE A6926
ILE A7005
ILE A6967
1.26A15.79
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2BU8_A_TF4A1379_1
(PYRUVATE
DEHYDROGENASE KINASE
ISOENZYME 2)
6w75 NSP16
(SARS-CoV-2)
4 / 8
LEU C6852
ILE C6926
ILE C7005
ILE C6967
1.27A15.79
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2BU8_A_TF4A1379_1
(PYRUVATE
DEHYDROGENASE KINASE
ISOENZYME 2)
6w75 NSP16
(SARS-CoV-2)
4 / 8
LEU C6848
TYR C6845
ILE C6926
ILE C6967
1.12A15.79
None
SAM  C7105 ( 4.5A)
None
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2BU8_A_TF4A1379_1
(PYRUVATE
DEHYDROGENASE KINASE
ISOENZYME 2)
6w75 NSP16
(SARS-CoV-2)
4 / 8
LEU A6978
ILE A6967
ILE A6955
ILE A6925
1.36A15.79
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2Q8H_A_TF4A438_1
([PYRUVATE
DEHYDROGENASE
[LIPOAMIDE]] KINASE
ISOZYME 1)
6wiq NSP7
NSP8
(SARS-CoV-2)
4 / 6
LEU A  60
ILE B 107
ILE A  68
ARG B 111
1.56A12.32
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2BU8_A_TF4A1379_1
(PYRUVATE
DEHYDROGENASE KINASE
ISOENZYME 2)
6wiq NSP7
NSP8
(SARS-CoV-2)
4 / 8
LEU A  56
ARG B  96
ILE B 107
ILE A  68
1.40A
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2Q8H_A_TF4A438_1
([PYRUVATE
DEHYDROGENASE
[LIPOAMIDE]] KINASE
ISOZYME 1)
6wji NUCLEOCAPSID PROTEIN
(SARS-CoV-2)
4 / 6
LEU E 331
TYR E 333
ILE F 337
ARG E 259
1.71A13.33
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2BU8_A_TF4A1379_1
(PYRUVATE
DEHYDROGENASE KINASE
ISOENZYME 2)
6wjt 2'-O-METHYLTRANSFERA
SE
(SARS-CoV-2)
4 / 8
LEU A6978
ILE A6955
ILE A6951
ILE A6925
1.32A
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2BU8_A_TF4A1379_1
(PYRUVATE
DEHYDROGENASE KINASE
ISOENZYME 2)
6wjt 2'-O-METHYLTRANSFERA
SE
(SARS-CoV-2)
4 / 8
LEU C6848
TYR C6845
ILE C6926
ILE C6967
1.14A
None
SAH  C7102 (-4.6A)
None
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2BU8_A_TF4A1379_1
(PYRUVATE
DEHYDROGENASE KINASE
ISOENZYME 2)
6wjt 2'-O-METHYLTRANSFERA
SE
(SARS-CoV-2)
4 / 8
LEU A6848
TYR A6845
ILE A6926
ILE A6967
1.14A
None
SAH  A7102 (-4.6A)
None
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2BU8_A_TF4A1379_1
(PYRUVATE
DEHYDROGENASE KINASE
ISOENZYME 2)
6wjt 2'-O-METHYLTRANSFERA
SE
(SARS-CoV-2)
4 / 8
LEU C7078
ILE C7080
ILE C7069
ILE C7065
1.24A
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2BU8_A_TF4A1379_1
(PYRUVATE
DEHYDROGENASE KINASE
ISOENZYME 2)
6wjt 2'-O-METHYLTRANSFERA
SE
(SARS-CoV-2)
4 / 8
LEU A6978
ILE A6967
ILE A6955
ILE A6925
1.39A
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2BU8_A_TF4A1379_1
(PYRUVATE
DEHYDROGENASE KINASE
ISOENZYME 2)
6wjt 2'-O-METHYLTRANSFERA
SE
(SARS-CoV-2)
4 / 8
LEU C6848
ILE C6926
ILE C7005
ILE C6967
1.30A
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2BU8_A_TF4A1379_1
(PYRUVATE
DEHYDROGENASE KINASE
ISOENZYME 2)
6wjt 2'-O-METHYLTRANSFERA
SE
(SARS-CoV-2)
4 / 8
LEU C6852
ILE C6926
ILE C7005
ILE C6967
1.28A
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2BU8_A_TF4A1379_1
(PYRUVATE
DEHYDROGENASE KINASE
ISOENZYME 2)
6wjt 2'-O-METHYLTRANSFERA
SE
(SARS-CoV-2)
4 / 8
LEU A6978
ILE A6955
ILE A6967
ILE A6925
1.26A
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2BU8_A_TF4A1379_1
(PYRUVATE
DEHYDROGENASE KINASE
ISOENZYME 2)
6wjt 2'-O-METHYLTRANSFERA
SE
(SARS-CoV-2)
4 / 8
LEU A6848
ILE A6926
ILE A7005
ILE A6967
1.30A
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2BU8_A_TF4A1379_1
(PYRUVATE
DEHYDROGENASE KINASE
ISOENZYME 2)
6wjt 2'-O-METHYLTRANSFERA
SE
(SARS-CoV-2)
4 / 8
LEU C6978
ILE C6955
ILE C6967
ILE C6925
1.24A
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2BU8_A_TF4A1379_1
(PYRUVATE
DEHYDROGENASE KINASE
ISOENZYME 2)
6wjt 2'-O-METHYLTRANSFERA
SE
(SARS-CoV-2)
4 / 8
LEU C7060
ILE C7080
ARG C7081
ILE C7079
1.67A
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2BU8_A_TF4A1379_1
(PYRUVATE
DEHYDROGENASE KINASE
ISOENZYME 2)
6wjt 2'-O-METHYLTRANSFERA
SE
(SARS-CoV-2)
4 / 8
LEU C6978
ILE C6967
ILE C6955
ILE C6925
1.34A
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2BU8_A_TF4A1379_1
(PYRUVATE
DEHYDROGENASE KINASE
ISOENZYME 2)
6wjt 2'-O-METHYLTRANSFERA
SE
(SARS-CoV-2)
4 / 8
LEU C6978
ILE C6955
ILE C6951
ILE C6925
1.19A
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2BU8_A_TF4A1379_1
(PYRUVATE
DEHYDROGENASE KINASE
ISOENZYME 2)
6wjt 2'-O-METHYLTRANSFERA
SE
(SARS-CoV-2)
4 / 8
ILE A6926
HIS A6867
ILE A6866
ILE A6925
1.56A
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2BU8_A_TF4A1379_1
(PYRUVATE
DEHYDROGENASE KINASE
ISOENZYME 2)
6wjt 2'-O-METHYLTRANSFERA
SE
(SARS-CoV-2)
4 / 8
LEU A7078
ILE A7080
ILE A7069
ILE A7065
1.24A
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2BU8_A_TF4A1379_1
(PYRUVATE
DEHYDROGENASE KINASE
ISOENZYME 2)
6wjt 2'-O-METHYLTRANSFERA
SE
(SARS-CoV-2)
4 / 8
LEU A6852
ILE A6926
ILE A7005
ILE A6967
1.27A
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2BU8_A_TF4A1379_1
(PYRUVATE
DEHYDROGENASE KINASE
ISOENZYME 2)
6wjt 2'-O-METHYLTRANSFERA
SE
(SARS-CoV-2)
4 / 8
ILE C6926
HIS C6867
ILE C6866
ILE C6925
1.56A
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2BU8_A_TF4A1379_1
(PYRUVATE
DEHYDROGENASE KINASE
ISOENZYME 2)
6wjt 2'-O-METHYLTRANSFERA
SE
(SARS-CoV-2)
4 / 8
LEU A7060
ILE A7080
ARG A7081
ILE A7079
1.58A
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2BU8_A_TF4A1379_1
(PYRUVATE
DEHYDROGENASE KINASE
ISOENZYME 2)
6wkq NSP16
(SARS-CoV-2)
4 / 8
LEU C7060
ILE C7080
ARG C7081
ILE C7079
1.66A
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2BU8_A_TF4A1379_1
(PYRUVATE
DEHYDROGENASE KINASE
ISOENZYME 2)
6wkq NSP16
(SARS-CoV-2)
4 / 8
LEU C6978
ILE C6955
ILE C6951
ILE C6925
1.20A
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2BU8_A_TF4A1379_1
(PYRUVATE
DEHYDROGENASE KINASE
ISOENZYME 2)
6wkq NSP16
(SARS-CoV-2)
4 / 8
ILE A6926
HIS A6867
ILE A6866
ILE A6925
1.56A
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2BU8_A_TF4A1379_1
(PYRUVATE
DEHYDROGENASE KINASE
ISOENZYME 2)
6wkq NSP16
(SARS-CoV-2)
4 / 8
LEU C7078
ILE C7080
ILE C7069
ILE C7065
1.25A
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2BU8_A_TF4A1379_1
(PYRUVATE
DEHYDROGENASE KINASE
ISOENZYME 2)
6wkq NSP16
(SARS-CoV-2)
4 / 8
ILE C6926
HIS C6867
ILE C6866
ILE C6925
1.56A
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2BU8_A_TF4A1379_1
(PYRUVATE
DEHYDROGENASE KINASE
ISOENZYME 2)
6wkq NSP16
(SARS-CoV-2)
4 / 8
LEU A6978
ILE A6955
ILE A6951
ILE A6925
1.32A
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2BU8_A_TF4A1379_1
(PYRUVATE
DEHYDROGENASE KINASE
ISOENZYME 2)
6wkq NSP16
(SARS-CoV-2)
4 / 8
LEU A6978
ILE A6955
ILE A6967
ILE A6925
1.26A
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2BU8_A_TF4A1379_1
(PYRUVATE
DEHYDROGENASE KINASE
ISOENZYME 2)
6wkq NSP16
(SARS-CoV-2)
4 / 8
LEU A6848
ILE A6926
ILE A7005
ILE A6967
1.31A
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2BU8_A_TF4A1379_1
(PYRUVATE
DEHYDROGENASE KINASE
ISOENZYME 2)
6wkq NSP16
(SARS-CoV-2)
4 / 8
LEU C6848
TYR C6845
ILE C6926
ILE C6967
1.14A
None
SFG  C7103 ( 4.5A)
None
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2BU8_A_TF4A1379_1
(PYRUVATE
DEHYDROGENASE KINASE
ISOENZYME 2)
6wkq NSP16
(SARS-CoV-2)
4 / 8
LEU A6852
ILE A6926
ILE A7005
ILE A6967
1.27A
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2BU8_A_TF4A1379_1
(PYRUVATE
DEHYDROGENASE KINASE
ISOENZYME 2)
6wkq NSP16
(SARS-CoV-2)
4 / 8
LEU C6978
ILE C6967
ILE C6955
ILE C6925
1.37A
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2BU8_A_TF4A1379_1
(PYRUVATE
DEHYDROGENASE KINASE
ISOENZYME 2)
6wkq NSP16
(SARS-CoV-2)
4 / 8
LEU C6978
ILE C6955
ILE C6967
ILE C6925
1.26A
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2BU8_A_TF4A1379_1
(PYRUVATE
DEHYDROGENASE KINASE
ISOENZYME 2)
6wkq NSP16
(SARS-CoV-2)
4 / 8
LEU A6848
TYR A6845
ILE A6926
ILE A6967
1.14A
None
SFG  A7103 ( 4.6A)
None
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2BU8_A_TF4A1379_1
(PYRUVATE
DEHYDROGENASE KINASE
ISOENZYME 2)
6wkq NSP16
(SARS-CoV-2)
4 / 8
LEU A7060
ILE A7080
ARG A7081
ILE A7079
1.63A
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2BU8_A_TF4A1379_1
(PYRUVATE
DEHYDROGENASE KINASE
ISOENZYME 2)
6wkq NSP16
(SARS-CoV-2)
4 / 8
LEU A7078
ILE A7080
ILE A7069
ILE A7065
1.25A
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2BU8_A_TF4A1379_1
(PYRUVATE
DEHYDROGENASE KINASE
ISOENZYME 2)
6wkq NSP16
(SARS-CoV-2)
4 / 8
LEU C6852
ILE C6926
ILE C7005
ILE C6967
1.28A
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2BU8_A_TF4A1379_1
(PYRUVATE
DEHYDROGENASE KINASE
ISOENZYME 2)
6wkq NSP16
(SARS-CoV-2)
4 / 8
LEU A6978
ILE A6967
ILE A6955
ILE A6925
1.37A
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2BU8_A_TF4A1379_1
(PYRUVATE
DEHYDROGENASE KINASE
ISOENZYME 2)
6wkq NSP16
(SARS-CoV-2)
4 / 8
LEU C6848
ILE C6926
ILE C7005
ILE C6967
1.31A
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2BU8_A_TF4A1379_1
(PYRUVATE
DEHYDROGENASE KINASE
ISOENZYME 2)
6wlc URIDYLATE-SPECIFIC
ENDORIBONUCLEASE
(SARS-CoV-2)
4 / 8
TYR A 343
ILE A 236
HIS A 250
ILE A 307
1.66A
U5P  A 401 (-3.8A)
None
U5P  A 401 (-4.1A)
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2BU8_A_TF4A1379_1
(PYRUVATE
DEHYDROGENASE KINASE
ISOENZYME 2)
6wlc URIDYLATE-SPECIFIC
ENDORIBONUCLEASE
(SARS-CoV-2)
4 / 8
LEU A 298
TYR A 194
ILE A 306
ILE A 307
1.72A
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2BU8_A_TF4A1379_1
(PYRUVATE
DEHYDROGENASE KINASE
ISOENZYME 2)
6wlc URIDYLATE-SPECIFIC
ENDORIBONUCLEASE
(SARS-CoV-2)
4 / 8
LEU A 298
ILE A 323
ILE A 296
ILE A 328
1.28A
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2BU8_A_TF4A1379_1
(PYRUVATE
DEHYDROGENASE KINASE
ISOENZYME 2)
6wlc URIDYLATE-SPECIFIC
ENDORIBONUCLEASE
(SARS-CoV-2)
4 / 8
LEU A  76
TYR A 325
ILE A  72
ILE A 144
1.72A
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2Q8H_A_TF4A438_1
([PYRUVATE
DEHYDROGENASE
[LIPOAMIDE]] KINASE
ISOZYME 1)
6wlc URIDYLATE-SPECIFIC
ENDORIBONUCLEASE
(SARS-CoV-2)
4 / 6
LEU B  76
TYR B 325
ILE B 144
ILE B  72
1.44A23.54
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2BU8_A_TF4A1379_1
(PYRUVATE
DEHYDROGENASE KINASE
ISOENZYME 2)
6wlc URIDYLATE-SPECIFIC
ENDORIBONUCLEASE
(SARS-CoV-2)
4 / 8
TYR B 343
ILE B 236
HIS B 250
ILE B 307
1.68A
U5P  B 401 (-3.8A)
None
U5P  B 401 (-4.1A)
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2BU8_A_TF4A1379_1
(PYRUVATE
DEHYDROGENASE KINASE
ISOENZYME 2)
6wlc URIDYLATE-SPECIFIC
ENDORIBONUCLEASE
(SARS-CoV-2)
4 / 8
LEU A 251
ILE A 306
ILE A 236
ILE A 307
1.54A
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2BU8_A_TF4A1379_1
(PYRUVATE
DEHYDROGENASE KINASE
ISOENZYME 2)
6wlc URIDYLATE-SPECIFIC
ENDORIBONUCLEASE
(SARS-CoV-2)
4 / 8
LEU B 251
ILE B 306
ILE B 236
ILE B 307
1.52A
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2Q8H_A_TF4A438_1
([PYRUVATE
DEHYDROGENASE
[LIPOAMIDE]] KINASE
ISOZYME 1)
6wlc URIDYLATE-SPECIFIC
ENDORIBONUCLEASE
(SARS-CoV-2)
4 / 6
LEU A  76
TYR A 325
ILE A 144
ILE A  72
1.44A23.54
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2BU8_A_TF4A1379_1
(PYRUVATE
DEHYDROGENASE KINASE
ISOENZYME 2)
6wlc URIDYLATE-SPECIFIC
ENDORIBONUCLEASE
(SARS-CoV-2)
4 / 8
LEU B 298
ILE B 323
ILE B 296
ILE B 328
1.29A
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2BU8_A_TF4A1379_1
(PYRUVATE
DEHYDROGENASE KINASE
ISOENZYME 2)
6wq3 2'-O-METHYLTRANSFERA
SE
(SARS-CoV-2)
4 / 8
LEU A6978
ILE A6955
ILE A6967
ILE A6925
1.28A
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2BU8_A_TF4A1379_1
(PYRUVATE
DEHYDROGENASE KINASE
ISOENZYME 2)
6wq3 2'-O-METHYLTRANSFERA
SE
(SARS-CoV-2)
4 / 8
LEU A7078
ILE A7080
ILE A7069
ILE A7065
1.19A
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2BU8_A_TF4A1379_1
(PYRUVATE
DEHYDROGENASE KINASE
ISOENZYME 2)
6wq3 2'-O-METHYLTRANSFERA
SE
(SARS-CoV-2)
4 / 8
LEU A6848
TYR A6845
ILE A6926
ILE A6967
1.13A
None
SAH  A7101 (-4.5A)
None
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2BU8_A_TF4A1379_1
(PYRUVATE
DEHYDROGENASE KINASE
ISOENZYME 2)
6wq3 2'-O-METHYLTRANSFERA
SE
(SARS-CoV-2)
4 / 8
LEU A6852
ILE A6926
ILE A7005
ILE A6967
1.28A
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2BU8_A_TF4A1379_1
(PYRUVATE
DEHYDROGENASE KINASE
ISOENZYME 2)
6wq3 2'-O-METHYLTRANSFERA
SE
(SARS-CoV-2)
4 / 8
ILE A6926
HIS A6867
ILE A6866
ILE A6925
1.56A
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2BU8_A_TF4A1379_1
(PYRUVATE
DEHYDROGENASE KINASE
ISOENZYME 2)
6wq3 2'-O-METHYLTRANSFERA
SE
(SARS-CoV-2)
4 / 8
LEU A6978
ILE A6955
ILE A6951
ILE A6925
1.33A
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2BU8_A_TF4A1379_1
(PYRUVATE
DEHYDROGENASE KINASE
ISOENZYME 2)
6wq3 2'-O-METHYLTRANSFERA
SE
(SARS-CoV-2)
4 / 8
LEU A7060
ILE A7080
ARG A7081
ILE A7079
1.64A
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2BU8_A_TF4A1379_1
(PYRUVATE
DEHYDROGENASE KINASE
ISOENZYME 2)
6wq3 2'-O-METHYLTRANSFERA
SE
(SARS-CoV-2)
4 / 8
LEU A6848
ILE A6926
ILE A7005
ILE A6967
1.30A
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2BU8_A_TF4A1379_1
(PYRUVATE
DEHYDROGENASE KINASE
ISOENZYME 2)
6wq3 2'-O-METHYLTRANSFERA
SE
(SARS-CoV-2)
4 / 8
LEU A6978
ILE A6967
ILE A6955
ILE A6925
1.45A
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2BU8_A_TF4A1379_1
(PYRUVATE
DEHYDROGENASE KINASE
ISOENZYME 2)
6yla SPIKE GLYCOPROTEIN
(SARS-CoV-2)
4 / 8
ILE A 418
ARG A 408
ILE A 410
ILE A 402
1.59A
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2BU8_A_TF4A1379_1
(PYRUVATE
DEHYDROGENASE KINASE
ISOENZYME 2)
6ywk NSP3 MACRODOMAIN
(SARS-CoV-2)
4 / 8
LEU A 126
TYR A 113
ARG A 141
ILE A 137
1.71A
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2BU8_A_TF4A1379_1
(PYRUVATE
DEHYDROGENASE KINASE
ISOENZYME 2)
6ywm NSP3 MACRODOMAIN
(SARS-CoV-2)
4 / 8
LEU A 126
TYR A 113
ARG A 141
ILE A 137
1.71A
None
None
EDO  A 206 (-4.2A)
EDO  A 206 (-4.6A)
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2BU8_A_TF4A1379_1
(PYRUVATE
DEHYDROGENASE KINASE
ISOENZYME 2)
7btf NSP12
NSP8
(SARS-CoV-2)
4 / 8
TYR A 273
ILE B 119
ARG B 111
ILE B 106
1.36A
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2BU8_A_TF4A1379_1
(PYRUVATE
DEHYDROGENASE KINASE
ISOENZYME 2)
7btf NSP12
NSP8
(SARS-CoV-2)
4 / 8
LEU A 271
ILE B 107
ILE B 119
ILE B 120
1.38A
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2BU8_A_TF4A1379_1
(PYRUVATE
DEHYDROGENASE KINASE
ISOENZYME 2)
7btf NSP12
NSP8
(SARS-CoV-2)
4 / 8
LEU A 329
TYR A 273
ARG B 111
ILE B 119
1.47A
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2BU8_A_TF4A1379_1
(PYRUVATE
DEHYDROGENASE KINASE
ISOENZYME 2)
7btf NSP8
(SARS-CoV-2)
4 / 8
LEU B 103
ILE B 120
ILE B 106
ILE B 119
1.61A
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2BU8_A_TF4A1379_1
(PYRUVATE
DEHYDROGENASE KINASE
ISOENZYME 2)
7btf NSP12
NSP8
(SARS-CoV-2)
4 / 8
LEU B 103
ILE B 120
ARG A 331
ILE B 107
1.52A
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2BU8_A_TF4A1379_1
(PYRUVATE
DEHYDROGENASE KINASE
ISOENZYME 2)
7btf NSP12
(SARS-CoV-2)
4 / 8
LEU A 895
HIS A 892
ILE A 856
ILE A 888
1.69A
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2BU8_A_TF4A1379_1
(PYRUVATE
DEHYDROGENASE KINASE
ISOENZYME 2)
7btf NSP12
NSP8
(SARS-CoV-2)
4 / 8
LEU A 271
ILE B 119
ILE B 106
ILE B 120
1.22A
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2BU8_A_TF4A1379_1
(PYRUVATE
DEHYDROGENASE KINASE
ISOENZYME 2)
7btf NSP12
(SARS-CoV-2)
4 / 8
ILE A  86
HIS A  82
ILE A 223
ILE A 201
1.58A
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2Q8H_A_TF4A438_1
([PYRUVATE
DEHYDROGENASE
[LIPOAMIDE]] KINASE
ISOZYME 1)
7bv1 NSP12
NSP8
(SARS-CoV-2)
4 / 6
LEU B 103
ILE B 120
ARG A 331
ILE B 107
1.69A21.39
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2BU8_A_TF4A1379_1
(PYRUVATE
DEHYDROGENASE KINASE
ISOENZYME 2)
7bv1 NSP8
(SARS-CoV-2)
4 / 8
LEU B 103
ILE B 120
ILE B 106
ILE B 119
1.52A
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2BU8_A_TF4A1379_1
(PYRUVATE
DEHYDROGENASE KINASE
ISOENZYME 2)
7bv1 NSP12
NSP8
(SARS-CoV-2)
4 / 8
LEU A 271
ILE B 119
ILE B 106
ILE B 120
1.39A
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2BU8_A_TF4A1379_1
(PYRUVATE
DEHYDROGENASE KINASE
ISOENZYME 2)
7bv1 NSP12
NSP8
(SARS-CoV-2)
4 / 8
LEU B 103
ILE B 120
ARG A 331
ILE B 107
1.47A
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2BU8_A_TF4A1379_1
(PYRUVATE
DEHYDROGENASE KINASE
ISOENZYME 2)
7bv2 NSP12
NSP8
(SARS-CoV-2)
4 / 8
LEU A 271
ILE B 107
ILE B 119
ILE B 120
1.48A
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2BU8_A_TF4A1379_1
(PYRUVATE
DEHYDROGENASE KINASE
ISOENZYME 2)
7bv2 NSP12
NSP8
(SARS-CoV-2)
4 / 8
LEU A 271
ILE B 119
ILE B 106
ILE B 120
1.21A
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2BU8_A_TF4A1379_1
(PYRUVATE
DEHYDROGENASE KINASE
ISOENZYME 2)
7bv2 NSP8
(SARS-CoV-2)
4 / 8
LEU B 103
ILE B 120
ILE B 106
ILE B 119
1.65A
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2BU8_A_TF4A1379_1
(PYRUVATE
DEHYDROGENASE KINASE
ISOENZYME 2)
7bv2 NSP12
NSP8
(SARS-CoV-2)
4 / 8
LEU A 270
ILE B 106
ILE B 119
ILE B 120
1.41A
None